• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    EVP and CFO Dougherty Neil covered exercise/tax liability with 10,223 shares and was granted 22,438 shares, decreasing direct ownership by 7% to 127,443 units (SEC Form 4)

    5/16/25 4:50:45 PM ET
    $KEYS
    Industrial Machinery/Components
    Industrials
    Get the next $KEYS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Dougherty Neil

    (Last) (First) (Middle)
    1400 FOUNTAINGROVE PARKWAY

    (Street)
    SANTA ROSA CA 95403

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Keysight Technologies, Inc. [ KEYS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    EVP and CFO
    3. Date of Earliest Transaction (Month/Day/Year)
    05/14/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/14/2025 A(1) 22,438 A $0 137,666.206 D(2)
    Common Stock 05/14/2025 F(3) 10,223 D $164.46 127,443.206 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. On May 14, 2025, pursuant to the Keysight Technologies, Inc. Long-Term Performance Program, 22,438 shares of common stock of Keysight Technologies, Inc. were awarded to the reporting person.
    2. Includes 164.96 shares acquired in an Employee Stock Purchase Plan under Section 423 of The Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3.
    3. The reporting person surrendered 10,223 shares to Keysight to satisfy the tax liability on the release of the Long-Term Performance shares in accordance with Rule 16b-3.
    Remarks:
    Jeffrey K. Li, Attorney-in-fact for Neil Dougherty 05/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $KEYS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KEYS

    DatePrice TargetRatingAnalyst
    12/16/2024$170.00 → $200.00Neutral → Overweight
    Analyst
    11/4/2024$158.00 → $180.00Equal Weight → Overweight
    Barclays
    7/23/2024$175.00Buy
    Vertical Research
    2/15/2024$184.00 → $170.00Overweight → Neutral
    JP Morgan
    9/15/2023$165.00Equal-Weight → Overweight
    Morgan Stanley
    9/5/2023$146.00 → $164.00Neutral → Buy
    Goldman
    8/18/2023$204.00 → $144.00Overweight → Equal Weight
    Barclays
    8/14/2023$163.00 → $148.00Neutral → Underperform
    BofA Securities
    More analyst ratings